|
1
|
O’Brien S, Thall PF and Siciliano MJ:
Cytogenetics of chronic myelogeneous leukemia. Baillieres Clin
Hematol. 10:259–276. 1997.
|
|
2
|
Al-Achkar W, Wafa A and Nweder MS: A
complex translocation t(5;9;22) in Philadelphia cells involving the
short arm of chromosome 5 in a case of chronic myelogenous
leukemia. J Exp Clin Cancer Res. 26:411–415. 2007.PubMed/NCBI
|
|
3
|
Shaffer L, Slovak M and Campbell L: An
International System for Human Cytogenetic Nomenclature. S Karger;
Basel: 2009
|
|
4
|
Liehr T, Heller A, Starke H, Rubtsov N,
Trifonov V, Mrasek K, Weise A, Kuechler A and Claussen U:
Microdissection based high resolution multicolor banding for all 24
human chromosomes. Int J Mol Med. 9:335–339. 2002.PubMed/NCBI
|
|
5
|
Mitelman F, Johansson B and Mertens F:
Mitelman Database of Chromosome Aberrations in Cancer. 2009,
http://cgap.nci.nih.gov/Chromosomes/Mitelman.
|
|
6
|
Johansson B, Fioretos T and Mitelman F:
Cytogenetic and molecular genetic evolution of chronic myeloid
leukemia. Acta Haematol. 107:76–94. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gale RP and Ben-Bassat I: Hybrid acute
leukaemia. Br J Haematol. 65:261–264. 1987. View Article : Google Scholar
|
|
8
|
Weir EG, Ali Ansari-Lari M, Batista DA,
Griffin CA, Fuller S, Smith BD and Borowitz MJ: Acute bilineal
leukemia: a rare disease with poor outcome. Leukemia. 21:2264–2270.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Richardson AL, Humphries CG and Tucker PW:
Molecular cloning and characterization of the t(2;14) translocation
associated with childhood chronic lymphocytic leukemia. Oncogene.
7:961–970. 1992.PubMed/NCBI
|
|
10
|
Satterwhite E, Sonoki T, Willis TG, Harder
L, Nowak R, Arriola EL, Liu H, Price HP, Gesk S, Steinemann D, et
al: The BCL11 gene family: involvement of BCL11A in lymphoid
malignancies. Blood. 98:3413–3420. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bezrookove V, van Zelderen-Bhola SL, Brink
A, Szuhai K, Raap AK, Barge R, Beverstock GC and Rosenberg C: A
novel t(6;14)(q25-q27;q32) in acute myelocytic leukemia involves
the BCL11B gene. Cancer Genet Cytogenet. 149:72–76. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gozzetti A, Davis EM, Espinosa R III,
Fernald AA, Anastasi J and Le Beau MM: Identification of novel
cryptic translocations involving IGH in B-cell non-Hodgkin’s
lymphomas. Cancer Res. 62:5523–5527. 2002.PubMed/NCBI
|
|
13
|
Barth TF, Martin-Subero JI, Joos S, Menz
CK, Hasel C, Mechtersheimer G, Parwaresch RM, Lichter P, Siebert R
and Möoller P: Gains of 2p involving the REL locus correlate with
nuclear c-Rel protein accumulation in neoplastic cells of classical
Hodgkin lymphoma. Blood. 101:3681–3686. 2003. View Article : Google Scholar
|
|
14
|
Inaba T, Oku N, Gotoh H, Murakami S, Oku
N, Itoh K, Ura Y, Nakanishi S, Shimazaki C, Nakagawa M, et al:
Philadelphia chromosome positive precursor B-cell acute
lymphoblastic leukemia with a translocation t(2;14)(p13;q32).
Leukemia. 5:719–722. 1991.PubMed/NCBI
|
|
15
|
Brown TA and McKnight SL: Specificities of
protein-protein and protein-DNA interaction of GABP alpha and two
newly defined ets-related proteins. Genes Dev. 6:2502–2512. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nambiar M, Kari V and Raghavan SC:
Chromosomal translocations in cancer. Biochim Biophys Acta.
1786:139–152. 2008.PubMed/NCBI
|
|
17
|
Coutte L, Monté D, Imai K, Pouilly L,
Dewitte F, Vidaud M, Adamski J, Baert JL and de Launoit Y:
Characterization of the human and mouse ETV1/ER81 transcription
factor genes: role of the two alternatively spliced isoforms in the
human. Oncogene. 18:6278–6286. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cai C, Hsieh CL, Omwancha J, Zheng Z, Chen
SY, Baert JL and Shemshedini L: ETV1 is a novel androgen
receptor-regulated gene that mediates prostate cancer cell
invasion. Mol Endocrinol. 21:1835–1846. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
King JC, Xu J, Wongvipat J, Hieronymus H,
Carver BS, Leung DH, Taylor BS, Sander C, Cardiff RD, Couto SS, et
al: Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation
in prostate oncogenesis. Nat Genet. 41:524–526. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Oberthuer A, Skowron M, Spitz R, Kahlert
Y, Westermann F, Mehler K, Berthold F and Fischer M:
Characterization of a complex genomic alteration on chromosome 2p
that leads to four alternatively spliced fusion transcripts in the
neuroblastoma cell lines IMR-5, IMR-5/75 and IMR-32. Gene.
363:41–50. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Carson-Walter EB, Watkins DN, Nanda A,
Vogelstein B, Kinzler KW and St Croix B: Cell surface tumor
endothelial markers are conserved in mice and humans. Cancer Res.
61:6649–6655. 2001.PubMed/NCBI
|
|
22
|
Davies G, Rmali KA, Watkins G, Mansel RE,
Mason MD and Jiang WG: Elevated levels of tumour endothelial
marker-8 in human breast cancer and its clinical significance. Int
J Oncol. 29:1311–1317. 2006.PubMed/NCBI
|
|
23
|
Venanzi FM, Petrini M, Fiammenghi L, Bolli
E, Granato AM, Ridolfi L, Gabrielli F, Barucca A, Concetti A,
Ridolfi R and Riccobon A: Tumor endothelial marker 8 expression
levels in dendritic cell-based cancer vaccines are related to
clinical outcome. Cancer Immunol Immunother. 59:27–34. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen QR, Bilke S, Wei JS, Whiteford CC,
Cenacchi N, Krasnoselsky AL, Greer BT, Son CG, Westermann F,
Berthold F, et al: cDNA array-CGH profiling identifies genomic
alterations specific to stage and MYCN-amplification in
neuroblastoma. BMC Genomics. 5:702004. View Article : Google Scholar : PubMed/NCBI
|
